A new systematic review shows that nasal spray adrenaline (via liquid or powder sprays) can be as fast or faster than injections for treating anaphylaxis, a possible needle-free alternative to EpiPen®.
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.
Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.
A non-invasive test for the early detection of oesophageal cancer has been developed by a team of researchers at the Medical Research Council (MRC) Cancer Cell Unit and is now being rolled out across Scotland.
15 new studies, backed by £19.6 million through the National Institute for Health Research, will expand research into diagnosing and treating long COVID.
As your specialist in Acute Care, Draeger Medical UK Ltd is focused on providing protective therapy solutions in the operating room, intensive care unit and neonatal intensive care unit. The aim has always been to improve clinical outcomes and reduce risks in acute care; which has never been truer than in the time of a global pandemic.
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
